Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/1999
05/27/1999WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/27/1999WO1999025357A1 USE OF 9-DEOXY-2', 9-α-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE
05/27/1999WO1999025336A1 Methods for preventing restenosis using tocotrienols
05/27/1999WO1999025321A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999WO1999003817A3 Aliphatic propargylamines as cellular rescue agents
05/27/1999CA2310319A1 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
05/27/1999CA2310232A1 Methods for preventing restenosis using tocotrienols
05/27/1999CA2309905A1 Isoquinoline derivatives and their therapeutical use
05/27/1999CA2309829A1 Preparation of terazosin hydrochloride dihydrate
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0746545B1 Nipecotic acid derivatives as antithrombic compounds
05/26/1999CN1217715A 2-thioxotetrahydropyrimidin-4-one derivative
05/26/1999CN1217713A Sulphur derivatives with retroamide bond as endothelin-converting enzyme inhibitors
05/26/1999CN1217662A Water soluble paclitaxel prodrugs
05/26/1999CN1217334A Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof
05/26/1999CN1217332A Metal protease inhibitor, preparation method therefor and medicinal composition containing same
05/26/1999CN1217327A D-proline derivative
05/25/1999US5907043 Coupling n-(4-methoxybenzoyl)-l-valyl-l-proline or a salt with 3-amino-4-methyl-1,1,1-trifluoro-2-pentanol forming (s)-1-(s)-2-(4-methoxybenzamido)-3-(2,2,2-trifluoro-1-hydroxy ethyl)propyl)pyrrolidine-2-carboxamide, oxidizing the product
05/25/1999US5906993 Anticancer, antitumor agent
05/25/1999US5906988 Methods of treatment using ranolazine and related piperazine derivatives
05/25/1999US5906974 Hemoglobin therapy in hemodialysis
05/25/1999CA2154257C Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
05/25/1999CA2038011C Processes for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024475A1 Piperazine-cyclodextrin complexes
05/20/1999WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024451A2 Adenosine a1 receptor agonists
05/20/1999WO1999024450A2 Adensine a1 receptor agonists
05/20/1999WO1999024449A2 Adenosine a1 receptor agonists
05/20/1999WO1999024436A1 1'-[4-[1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro [isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides
05/20/1999WO1999024433A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
05/20/1999WO1999024421A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
05/20/1999WO1999024420A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999WO1999024405A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024398A2 Urea derivatives and their use as integrin inhibitors
05/20/1999WO1999024397A1 Benzocycloheptene derivatives
05/20/1999WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999WO1999024017A1 Novel oral dosage form for carvedilol
05/20/1999WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
05/20/1999WO1999016753A3 Tricyclic 3-oxo-propanenitrile compounds
05/20/1999WO1999015526A3 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
05/20/1999WO1999011666B1 N-terminal modifications of rantes and methods of use
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999DE19750529A1 New heterocyclic alpha-hydroxycarboxylic acid derivatives useful for treating hypertension, chronic coronary insufficiency, asthma, prostate cancer etc.
05/20/1999DE19750085A1 New 2-phenyl-imidazotriazinone derivatives used for treating cardiovascular, cerebrovascular and urogenital disorders
05/20/1999CA2309609A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
05/20/1999CA2309542A1 Novel oral dosage form for carvedilol
05/20/1999CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999CA2309200A1 Adenosine a1 receptor agonists
05/20/1999CA2309199A1 Adensine a1 receptor agonists
05/20/1999CA2309177A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999CA2308716A1 Urea derivatives and their use as integrin inhibitors
05/20/1999CA2308586A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999CA2306465A1 Piperazine-cyclodextrin complexes
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916679A1 Benzazepinone-N-acetic acid derivatives having a phosphonic acid group, process for their preparation and medicaments containing these compounds
05/19/1999EP0916671A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them
05/19/1999EP0916337A2 Use of inhibitors of the sodium-hydrogen exchange in the manufacture of amedicament for reducing unwanted effects of compounds on the heart.
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application
05/19/1999EP0915881A1 Pyrroloazepine compounds
05/19/1999EP0915876A1 Tricyclic benzazepine vasopressin antagonists
05/19/1999EP0915860A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
05/19/1999EP0915859A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/19/1999EP0915856A1 Diphenyl heterocycles as potassium channel modulators
05/19/1999EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses
05/19/1999EP0915830A1 Benzoylpropionic acid ester derivatives
05/19/1999EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/19/1999EP0915704A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
05/19/1999EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
05/19/1999EP0915651A1 Il-8 receptor antagonists
05/19/1999EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
05/19/1999EP0720599B1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
05/19/1999CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors
05/19/1999CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them
05/19/1999CN1216763A Sulfamine sbstituted benzodihydrofuran, method for preparing same, use as medicine, medicine prepns. contg. same
05/19/1999CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives
1 ... 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 ... 1595